Economic portfolio
Invesco India Pharma and Healthcare Fund
INVESCO Invesco Mutual Fund Sep 2026 — Sep 2026 1 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Mirae Asset Healthcare FundMirae Asset · 9 shared46.5%
- EODWHFEdelweiss · 8 shared44.4%
- LIC MF HEALTHCARE FUNDLIC · 9 shared43.6%
- PGIM INDIA HEALTHCARE FUNDPGIM India · 9 shared43.6%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 10 shared43.4%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 7 shared43.4%
- DSP Nifty Healthcare Index FundDSP · 7 shared43.4%
- DSP Nifty Healthcare ETFDSP · 7 shared43.4%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Max Healthcare Institute Limited | Healthcare | Large Cap | 11.01% | 41.72 Cr | 0.04 Cr | by Sep 2026 (1 mo+) |
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 10.34% | 39.17 Cr | 0.02 Cr | by Sep 2026 (1 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 9.92% | 37.58 Cr | 0.02 Cr | by Sep 2026 (1 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 9.23% | 34.96 Cr | 42,818 | by Sep 2026 (1 mo+) |
| Manipal Health Enterprises Limited | Not classified | — | 9.17% | 34.74 Cr | 0.05 Cr | by Sep 2026 (1 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 9.02% | 34.17 Cr | 36,777 | by Sep 2026 (1 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 8.04% | 30.47 Cr | 0.02 Cr | by Sep 2026 (1 mo+) |
| Dr. Agarwal's Health Care Limited | Not classified | Small Cap | 7.27% | 27.54 Cr | 0.06 Cr | by Sep 2026 (1 mo+) |
| CORONA Remedies Limited | Not classified | Small Cap | 7.05% | 26.70 Cr | 0.01 Cr | by Sep 2026 (1 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 5.66% | 21.45 Cr | 44,689 | by Sep 2026 (1 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 5.59% | 21.18 Cr | 90,716 | by Sep 2026 (1 mo+) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 5.43% | 20.57 Cr | 0.03 Cr | by Sep 2026 (1 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 2.29% | 8.67 Cr | 0.01 Cr | by Sep 2026 (1 mo+) |
Half of its current holdings have been held for 1 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| No comparable position changes are available for this portfolio. | |||
Changes compare consecutive month-end disclosures for this portfolio only.